IC
Immunoclin Corp Stock: price and insider trades · United States
Immunoclin Corp: what insiders have been doing
Immunoclin Corp is a listed company. Its directors and officers file their transactions with SEC (Form 4). The past year has been quiet: not a single insider filing for Immunoclin Corp. The previous disclosure was published on 1 April 2016.
Since 2015, the database holds no purchases and 2 sales by insiders of the company.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€9,227
2 ops. · all time
Last declaration on 1 April 2016
Declarations5 total
- 10,000,000 shares@ US$0.001Common StockSEC:0001468429-16-000023:0
- 500,000 shares@ US$0.001Series A Preferred StockSEC:0001468429-16-000023:1
- 2,000,000 shares@ US$5.00Common StockSEC:0001621608-15-000001:0
- 1,000,000 shares@ US$4.00Common StockSEC:0001621170-15-000003:0
- 1,000,000 shares@ US$5.00Common StockSEC:0001468429-15-000005:0
5 of 5 declarations
About Immunoclin Corp
Immunoclin Corp is a company listed on the XNAS market, specializing in the development of innovative solutions in the healthcare sector. It focuses on the research and commercialization of clinical products.
